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Abstract  
Introduction 
Respiratory syncytial virus (RSV) causes a significant respiratory disease burden 
in the under 5 population. The transmission pathway to young children is not 
fully quantified in low-income settings, and this information is required to design 
interventions.  
Methods  
We used an individual level transmission model to infer transmission 
parameters using data collected from 493 individuals distributed across 47 
households over a period of 6 months spanning the 2009/2010 RSV season. A 
total of 208 episodes of RSV were observed from 179 individuals. We model 
competing transmission risk from within household exposure and community 
exposure while making a distinction between RSV groups A and B.  
Results 
We find that individuals are more likely to get infected by a member of the same 
household than from an external source; the rate of pair-wise transmission is 
lower in larger households (≥8 occupants) than smaller households (relative 
proportion =0.42 (95% CrI: 0.26-0.7)); symptomatic individuals are 2-7 times 
more infectious than asymptomatic individuals i.e. 2.48 (95% CrI: 1.22-5.57) 
among symptomatic individuals with low viral load and 6.7(95% CrI: 2.56-16) 
among symptomatic individuals with high viral load; previous infection reduces 
susceptibility to re-infection within the same epidemic by 47% (95% CrI: 17%-
68%) for homologous RSV group and 39% (95%CrI: -8%-69%) for heterologous 
group; RSV B is more frequently introduced into the household, and RSV A is 
more rapidly transmitted once in the household.  
Discussion 
Our analysis presents the first transmission modelling of cohort data for RSV and 
we find that it is important to consider the household social structuring and 
household size when modelling transmission. The increased infectiousness of 
symptomatic individuals implies that a vaccine against RSV related disease 
would also have an impact on infection transmission. Together, the weak cross 
immunity between RSV groups and the possibility of different transmission 
niches could form part of the explanation for the group co-existence.  
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Introduction 
Respiratory syncytial virus (RSV) is an ubiquitous RNA virus infection that is a 
major cause of lower respiratory tract disease in children under 5 years of age 
worldwide (Nair et al., 2010; Shi et al., 2015).  The estimated global burden of 
RSV associated acute lower respiratory tract infection (ALRI) in 2015 in under 5 
year olds is 33.0 million (21.6-50.3), most of which occurs in developing 
countries (30.5 million) (Shi et al., 2017). Of the 3.2 (2.7 -3.8) million hospital 
admissions associated with RSV in the under 5s, 1.4 (1.2-1.7) million occurred in 
the 0-5 months age group, and 1.2 (1.0-1.5) million occurred in developing 
countries.  
 
Despite 50 years of vaccine research none is yet licensed for the prevention of 
RSV infection or disease.  There are currently over fifty vaccines in different 
stages of development: many with the aim of prevention of early infant RSV 
disease.  While the most advanced (in phase III trials) is a maternal vaccine to 
boost transplacental antibody transfer (Thomas, 2017; “RSV Vaccine Snapshot,” 
2016, “WHO | WHO vaccine pipeline tracker,” 2016),  a variety of product types 
and range of strategies for protecting young children are under investigation 
including indirect protection  by targeting older infants, elder siblings and family 
cocooning (Anderson et al., 2013; Kinyanjui et al., 2015; Poletti et al., 2015).   
 
Prior to vaccine introduction, drivers of transmission need to be well understood 
in order to predict the potential public health impact of implementation. 
Investigating outbreaks within the household setting could help to further 
characterize RSV transmission. The household is an important unit of study for 
diseases that are transmitted through close contact. The quantitative analysis of 
household outbreaks has been conducted for influenza (Cauchemez et al., 2009, 
2004; House et al., 2012; Klick et al., 2011; Lau et al., 2015; Wu et al., 2006; Yang 
et al., 2015). This has led to quantification of transmissibility within the 
household, improved understanding of the factors that determine level of 
transmission such as household size and effectiveness of different household 
level interventions (Tsang et al., 2016). To date studies of RSV transmission 
within households or families have been largely observational. One of the 
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earliest is a household cohort study in the USA in which 36 families were 
followed up for 2 months during the 1974/1975 RSV season (Hall et al., 1976). 
This study found that RSV attack rates in households were high, more so in 
infants. Older siblings to infants were found to be the most likely index cases in 
household outbreaks, and illness was found to have an age-related severity. 
Several other studies over the years across different settings have highlighted 
the importance of older children in household outbreaks (Heikkinen et al., 2015; 
Jacoby and Glass, 2017; Munywoki et al., 2014) which could have implications 
for control strategies (Graham, 2014).  
 
In Kenya, a household cohort study conducted in a rural coastal community 
during the 2009/2010 RSV epidemic has revealed several patterns. In addition 
to the importance of older children (Munywoki et al., 2014), bigger household 
size and infection with RSV group B, among other factors, were found to be 
independently associated with increased risk of asymptomatic infection 
(Munywoki et al., 2015a); shedding duration estimates (using molecular 
diagnostics) were 11.2 days on average, and longer than  the previous range 
reported of 3.9-7.4 days (Munywoki et al., 2015b); individuals experiencing the 
first infection of an RSV season were found to shed more virus relative to 
secondary infections; children under 1 year old, symptomatic shedders and RSV 
A and B co-infected individuals were identified as the most likely to transmit due 
to their relatively higher viral loads (Wathuo et al., 2016). 
 
RSV can be categorized into two antigenically and genetically distinct groups, 
RSV A and RSV B (Cane, 2001). These groups, thought to have diverged about 
350 years ago (Zlateva et al., 2005), have been observed to co-exist 
geographically and temporally with most outbreaks being dominated by RSV A 
and, in some locations, clear patterns of alternating dominance (White et al., 
2005). Within the RSV groups are subgroups or genotypes whose frequency 
changes from season to season, with some genotypes undergoing complete 
replacement over time (Agoti et al., 2013, 2012; Park et al., 2017; Rodriguez-
Fernandez et al., 2017; Song et al., 2017; Thongpan et al., 2017). This pattern of 
group and genotype replacement is thought to be due to a herd immunity effect 
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(Botosso et al., 2009; Cane, 2001; Pretorius et al., 2013; White et al., 2005). A 
phylogenetic analysis of RSV A sequences from the Kenyan household study 
showed that most infections arise from a single variant introduction followed by 
accumulation of household specific variation, i.e. cases arise more from within 
household spread rather than multiple introductions (Agoti et al., 2017). 
 
However, there is yet to be a mechanistic analysis of RSV household outbreak 
data that consolidates information on the characteristics of infection episodes 
and characteristics of the host population into a single dynamic framework.  
Inference could then be drawn on the competing risks of within household 
exposure and community (external to household) exposure, in order to quantify 
the importance of households in RSV transmission. We proposed to use an 
individual-based approach within a Bayesian framework to analyze the 
household cohort data from Kenya to further understand transmission 
dynamics. We also explore the differences and interactions between RSV groups. 
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Material and methods 
Data 
The data to be used were collected from a household cohort study conducted in 
rural coastal Kenya within the Kilifi Health and Demographic Surveillance 
System (KHDSS) during the 2009/2010 RSV epidemic. Details of the study have 
been published elsewhere (Munywoki, 2013; Munywoki et al., 2015a, 2015b, 
2014). In brief, the infant-centric study recruited household members using the 
criteria that the infant was born after 1 April 2009 (after the previous RSV 
epidemic) and had at least 1 older sibling less than 13 years old. Deep 
nasopharyngeal swab (NPS) samples were collected every 3-4 days regardless of 
symptoms, together with a record of clinical illness.  The samples were tested for 
RSV antigen using an in-house real-time multiplex polymerase chain reaction 
(PCR) assay. A sample was considered antigen positive if the PCR cycle threshold 
(Ct) value was 35.0 or below. Positive Ct values were then converted to viral load 
(log10 RNA equivalent). A household was defined as a group of individuals living 
in the same compound and eat together. The data contain information from 493 
individuals spread across 47 households whose dates of data collection span 180 
days. The household sizes range from 4 to 37 occupants with a median of 8 
members.  
 
An RSV A/B shedding episode is defined as a period within which an individual 
provided PCR positive samples for RSV A/B that were no more than 14 days 
apart. A shedding episode is referred as symptomatic if within the window of 
virus shedding, there is at least one day where symptoms were recorded. The 
symptoms of interest are those of an acute respiratory illness (ARI), which are: 
cough, or nasal discharge/blockage, or difficulty breathing. Sampling of the study 
population was done in 3-4 day intervals, as such, complete duration of shedding 
and ARI episodes had to be imputed, and missing viral loads were linearly 
interpolated. Shedding durations were imputed first, after which, if there were 
any days of recorded ARI within shedding episodes, the total duration of the ARI 
was imputed based on the days of recorded symptoms. As such, the length of an 
ARI episode within a shedding episode can be ≤ length of related shedding 
episode. 
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Details of the imputation of episodes and interpolation of viral load can be found 
in the supplementary appendix section.  
 
We categorized days of shedding according to viral load and symptoms into 4 
categories to compare infectiousness: low viral load and asymptomatic, high 
viral load and asymptomatic, low viral load and symptomatic and, high viral load 
and symptomatic. High viral load is defined as >6 log10 viral copy number (or a 
PCR Ct value <23.05). 
 
Transmission model 
We built a mechanistic model for RSV that tracks infection onset at the individual 
host level. The main assumptions about transmission are contained in the 
equation giving the per capita rate of exposure (to infection) per unit time, also 
known as the infection hazard. The rate of exposure to a particular RSV group 
(index g) is given for a particular individual, (index i) from a given household 
(index h) at a given day (index t) and is specified by the notation 𝜆𝑖,ℎ,𝑔(𝑡).  We 
assume that an individual can be exposed to infection in the household they 
occupy and from external infection sources and as such, decompose the rate of 
exposure into two parts, a within household component and a community 
component.  
Within household exposure: 
For an individual i, in household h, the rate of exposure at a given time t, is a 
summation of rates from all the infectious individuals in their household. The 
rate of exposure from a single infectious housemate (index j) is assumed to 
depend on the size of the household and the viral load and symptom status. We 
consider the household size effect as a binary variable where a house with >8 
members is considered large. We consider viral load and symptom status as one 
variable with 4 categories: low viral load and no symptoms, high viral load and 
no symptoms, low viral load and symptomatic, high viral load and symptomatic. 
The household rate of exposure from individual j to i is thus give as: 
 
𝐻𝐻_𝑅𝑖𝑠𝑘ℎ,𝑔,𝑗→𝑖(𝑡) =  𝜂𝑔  ×  𝜓𝐻(𝐻𝑜𝑢𝑠𝑒ℎ𝑜𝑙𝑑_𝑠𝑖𝑧𝑒𝑖)  × 𝜓𝐼,𝑖𝑛𝑓(𝐼𝑛𝑓𝑒𝑐𝑡𝑖𝑣𝑖𝑡𝑦𝑗,ℎ,𝑔(𝑡)) 
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𝜂𝑔 is the baseline rate of exposure in the household which is estimated for each 
of the two RSV groups, RSV A and RSV B. 𝜓𝐻  is the coefficient modifying 
exposure in large household relative to small households and 𝜓𝐼,𝑖𝑛𝑓is the 
coefficient modifying infectiousness based on viral load and symptom status. The 
within household rate of exposure only affects susceptible individuals who are 
present in the household, as such this rate is multiplied by a binary variable 
𝑀𝑖,ℎ(𝑡) =0 if i is not present in the household at time t and 𝑀𝑖,ℎ(𝑡)=1 if i is 
present. 
Community exposure: 
For a susceptible individual i, this external to the household source of exposure 
is assumed to represent both sampled and unsampled cases from other 
households. Community exposure is assumed to depend on the age of the 
susceptible individual and time. Age is treated as a categorical variable. The 
community rate of exposure is thus give as:  
 
𝐶𝑜𝑚𝑚𝑅𝑖𝑠𝑘𝑖,𝑔(𝑡) = 𝜀𝑔  ×  𝑓𝑔(𝑡)  × 𝜓𝐸,𝑎𝑔𝑒(𝐴𝑔𝑒_𝑔𝑟𝑜𝑢𝑝𝐸,𝑖) 
 
𝜀𝑔 is the baseline rate of exposure from the community, which is estimated for 
each of the two RSV groups. 𝜓𝐸,𝑎𝑔𝑒  is the coefficient modifying the rate of 
community exposure by age. For each RSV group, we have 𝑓𝑔(𝑡), a time-unit 
dependent curve that modifies the community rate of exposure over time, in this 
case the time period of interest is the duration of the study. We wanted this 
curve to represent the background epidemic dynamics in the local zone from 
which the data was collected; as such we proceeded to use the same household 
dataset to generate it.  
The data are calibrated in days and are at the individual level, but to obtain the 
background community rate, we assumed that this background rate is scalable 
from the weekly household-level rate of primary incidence, denoted 𝜆𝐻𝐻(𝑡𝑤). If 
we treat 𝜆𝐻𝐻(𝑡𝑤) as the hazard rate in a probability distribution, we can estimate 
it using the following model: 
𝐼𝑐(𝑡𝑤) = 𝑁𝐻𝐻 (1 −  𝑒𝑥𝑝
− ∫ 𝜆𝐻𝐻(𝑠)
𝑡𝑤
0 )  
  𝐼(𝑡𝑤) = 𝑚𝑎𝑥(0, [𝐼𝑐(𝑡𝑤) − 𝐼𝑐(𝑡𝑤 − 1)])  
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Where 
NHH = Total number of households in the study 
I(𝑡𝑤) = Average weekly household-level incidence of primary infection  
IC(𝑡𝑤) = Weekly cumulative household-level incidence of primary 
infection 
We further assumed that 𝜆𝐻𝐻(𝑡𝑤) = 𝑎1𝑒𝑥𝑝
−(
𝑡𝑤−𝑏1
𝑐1
)
2
, giving it a bell-shape, and 
estimated {a1, b1, c1} using maximum likelihood assuming Poisson distributed 
data.  
Once 𝜆𝐻𝐻(𝑡𝑤) was estimated for each RSV group, it was scaled such that it ranges 
between 0 and 1 using the formula 𝑋𝑖
𝑆𝑐𝑎𝑙𝑒𝑑 =
𝑋𝑖−min ({𝑋})
max({𝑋})−min ({𝑋})
. As such, 
 𝑓𝑔(𝑡𝑤) =
𝜆𝐻𝐻(𝑡𝑤)−min ({𝜆𝐻𝐻(1),𝜆𝐻𝐻(2)…𝜆𝐻𝐻(𝑡𝑤)})
max({𝜆𝐻𝐻(1),𝜆𝐻𝐻(2)…𝜆𝐻𝐻(𝑡𝑤)})−min ({𝜆𝐻𝐻(1),𝜆𝐻𝐻(2)…𝜆𝐻𝐻(𝑡𝑤)})
. To turn 𝑓𝑔(𝑡𝑤) 
into a daily scale, the value for a given week were assumed to be the values for 
every day of that week. The resultant background community curves for RSV A 
and B are shown in Figure 1 
 
Figure 1:  Establishing the background community rate function. The figures 
in the top row show a comparison of data and model fit of the weekly incidence 
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of primary household outbreaks that was used to derive the background 
community rate function. Top left: RSV A data and model fit; Top right: RSV B 
data and model fit; Bottom: Comparing the estimated background community 
rate function for RSV A and RSV B.  
Finally, we assume that susceptibility can be modified according to an 
individual’s infection history within the same epidemic, and their age. These two 
components are combined into an equation representing relative susceptibility 
to infection as shown below  
 
𝑆𝑖,𝑔(𝑡) = exp (𝜙𝑌,ℎ𝑖𝑠𝑡(𝐼𝑛𝑓𝑒𝑐𝑡𝑖𝑜𝑛_𝐻𝑖𝑠𝑡𝑜𝑟𝑦𝑖(𝑡)) +  𝜙𝑋,𝑎𝑔𝑒(𝐴𝑔𝑒_𝑔𝑟𝑜𝑢𝑝𝑆,𝑖)) 
 
𝜙𝑋,𝑎𝑔𝑒is the coefficient modifying susceptibility by age. We categorized infection 
history into four groups: no previous infection, recovered from an RSV A 
infection, recovered from an RSV B infection, recovered from both RSV A and B. 
 ϕY,hist is the coefficient modifying susceptibility to a particular RSV group 
depending on infection history in the following three ways: by 𝑒𝑥𝑝ϕ𝑌,ℎ𝑜𝑚 if an 
individual has previously experienced and recovered from infection by the same 
group (homologous infection), 𝑒𝑥𝑝ϕ𝑌,ℎ𝑒𝑡  if the individual has previously 
experienced and recovered from infection by a different group (heterologous 
infection) and by 𝑒𝑥𝑝(ϕ𝑌,ℎ𝑜𝑚+ϕ𝑌,ℎ𝑒𝑡) if an individual has previously experienced 
and recovered from both RSV A and RSV B infection. This mechanism of 
interaction between RSV A and B is similar to that applied in a compartmental 
model used to analyze data from the UK and Finland (White et al., 2005).  
In combination, all the above assumptions result in the rate of exposure equation 
shown below 
1) 𝜆𝑖,ℎ,𝑔(𝑡) = Rate of exposure of individual i in household h with RSV 
group g at time t. 
𝜆𝑖,ℎ,𝑔(𝑡) = 𝑆𝑖,𝑔(𝑡) [𝑀𝑖,ℎ(𝑡) ∑ 𝐻𝐻_𝑅𝑖𝑠𝑘ℎ,𝑔,𝑗→𝑖(𝑡)
𝑗≠𝑖
+ 𝐶𝑜𝑚𝑚_𝑅𝑖𝑠𝑘𝑖,𝑔(𝑡)] 
The assumption of how age and infection history modify the rate of exposure is 
similar to the assumptions made in a proportional hazards model.  
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Additional details on the data variables and parameters are given in Table 1.  
 
Table 1: Model Notation. 
Symbol Name Type Description 
i   Index Index of individual 
h  Index Index of household 
g  Index Index of RSV group type, either A 
or B 
t   Index Index of time in days 
𝑰𝒋,𝒉,𝒈(𝒕) Infectivity Data* Categorical data variable for 
infectious individuals indicating 
level of infectivity categorized by 
viral load and symptom status at 
time t. The categories are: low 
viral load and asymptomatic 
(reference group), high viral load 
and asymptomatic, low viral load 
and symptomatic and, high viral 
load and symptomatic. High viral 
load is defined as >6 log10 viral 
copy number. 
𝒀𝒊(𝒕) Infection_
history 
Data Variable indicating if an 
individual has experienced and 
recovered from an infection by a 
particular RSV group in the 
current epidemic at time t. 
𝑿𝒊 Age_grou
pS 
Data Categorical data variable 
indicating the susceptibility age 
group of an individual. The age 
groups are <1 year (reference 
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group), 1 - <5 years, 5 - <15 
years and ≥15 years. 
𝑴𝒊,𝒉(𝒕)  Data Binary data variable indicating if 
an individual is present in the 
household at time t. Absence 
from the household means that 
an individual was not present at 
the point of sample collection 
and thus in the model they can 
only get infection from a 
community source and not from 
an infectious housemate (not 
sampled and not at household 
risk). Individuals who were 
present but not sampled are 
exposed to both household and 
community source transmission 
in the models (not sampled but 
at household risk).  
𝑯𝒊 Househol
d_size 
Data* Binary data variable indicating 
whether the individual lives in a 
large or small household. A small 
household (reference group) has 
<8 individuals. 
𝑬𝒊 Age_grou
pE 
Data Categorical data variable 
indicating the community 
exposure age group of an 
individual. The age groups are <1 
year (reference group), 1 - <5 
years and ≥5 years. 
𝝓𝑿,𝒂𝒈𝒆 Sus.age.2 
Sus.age.3 
Parameter Coefficients modifying 
susceptibility to RSV depending 
 14 
Sus.age.4 on age, applied to the age group 
covariate Xi. Sus.age.2 estimates 
the effect being in age group 1-5 
years, Sus.age.3 the effect of 
group 5-15 and Sus.age.4 of 
group ≥15 relative to group <1 
year.  
𝝓𝒀,𝒉𝒊𝒔𝒕 
 
Prev.hom 
Prev.het 
Parameter Coefficients modifying 
susceptibility to infection by a 
particular RSV group depending 
on infection history. Prev.hom 
estimates the effect of a previous 
homologous group infection, 
while Prev.het estimates the 
effect of a previous heterologous 
group infection. Applied to the 
categorical covariate Yi(t). 
𝝍𝑯 HH.size Parameter Coefficient modifying the 
amount of within household 
exposure by household size. 
HH.size estimates the effect of 
being in a large household 
relative to a small one. Applied to 
covariate Hi. 
𝜼𝒈 HH.rsv.a 
HH.rsv.b 
Parameter Baseline rate of within 
household exposure by RSV 
group 
𝝍𝑰,𝒊𝒏𝒇 High.Asy
m 
Low.Sym 
High.Sym 
Parameter Coefficients modifying 
infectiousness by viral load and 
symptom status. Relative to 
shedding low viral load and 
being asymptomatic, High.Asym 
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estimates the effect of shedding 
high viral load and being 
asymptomatic, Low.Sym the 
effect of shedding low viral load 
and being symptomatic and 
High.Sym the effect of shedding 
high viral load and being 
symptomatic. Applied to the 
infectivity covariate 𝑰𝒋,𝒉,𝒈(𝒕). 
𝝍𝑬,𝒂𝒈𝒆 
 
Exp.age.2 
Exp.age.3 
Parameter Coefficients modifying the rate of 
community exposure by age 
group. Exp.age.2 estimates the 
effect being in age group 1-5 
years and Exp.age.3 the effect of 
group ≥5, relative to the <1-year 
age group. Applied to the age 
group covariate Ei 
𝜺𝒈 
 
Comm.rsv.
a 
Comm.rsv.
b 
Parameter Community transmission 
coefficient by RSV group 
𝒇𝒈(𝒕)  Estimated  RSV group specific, time-
dependent curve modifying the 
rate of community exposure.  
𝑼𝒊,𝒉,𝒈  Data Set of group specific onset days 
for an individual i in household h 
used in calculating the likelihood 
of an individual’s data. 
* The choice of cut-off for high viral load and large households was based on 
initial runs of the inference algorithm that explored different cut-offs for each. 
The choice of 6 log10 copy number for high viral load and 8 persons for large 
households led to the best convergence. 
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Following on from the rate of exposure equation are two additional nested 
equations that make up the model. 
 
2) 𝛼𝑖,ℎ,𝑔(𝑡) = Probability of infection following exposure per day i.e. 
individual enters the latent phase 
𝛼𝑖,ℎ,𝑔(𝑡) = (1 − 𝑒𝑥𝑝
−𝜆𝑖,ℎ,𝑔(𝑡)) 
3) 𝑝𝑖,ℎ,𝑔(𝑡) = Probability of starting to shed i.e. individual enters the 
infectious phase  
𝑝𝑖,ℎ,𝑔(𝑡) = ∑ 𝜃𝑙𝛼𝑖,ℎ,𝑔(𝑡 − 𝑙)
𝐿
𝑙=0
 
Where L is the maximum latent period and 𝜃𝑙  is the probability that the 
latent period is exactly 𝑙 days. For 𝑙 = {0,1,2,3,4,5} days, we have the 
following probabilities [0,0,4,4,3,1]/12= [0, 0,0.33,0.33,0.25,0.083] (Lee et 
al., 2004). The same latency distribution is used for RSV A and B.  
The likelihood of an individual’s data, given the above model thus becomes: 
𝐿𝑖 =  ∏ [ ∏ 𝑝𝑖,ℎ,𝑔(𝑢)
𝑢∈𝑈𝑖,ℎ,𝑔
∏ (1 − 𝑝𝑖,ℎ,𝑔(𝑢))
𝑢∉𝑈𝑖,ℎ,𝑔
]
𝑔
 
 
The model as presented can be reduced to fit for a single RSV group or for RSV as 
a single pathogen with no distinction between RSV A and B. Attempts to model 
household size as a continuous variable were unsuccessful possibly due to our 
small sample size and hence we modeled transmission within the household as a 
density dependent process but identified households as either large or small and 
found that the cut-off between categories of 8 provided the best fit.   
Parameter inference 
We used Bayesian inference to obtain estimates of the parameters. Adaptive 
Metropolis Markov Chain Monte Carlo was used as implemented in the R 
software package fitR (Camacho and Funk, 2017), function mcmcMH . The 
mcmcMH function can adapt the size of the proposal distribution, such that the 
acceptance rate is close to 23.4%, and the shape using the Adaptive metropolis 
algorithm as in (Roberts and Rosenthal, 2009); the difference in size and shape 
adaptation being in the scaling factor used. In brief, the method builds a Markov 
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chain which allows us to sample from the posterior distribution P(φ|D) of the 
parameters given the data, where φ={𝜙𝑋,𝑎𝑔𝑒 , 𝜙𝑌,ℎ𝑖𝑠𝑡, 𝜓𝐻 , 𝜂𝑔 , 𝜓𝐼,𝑖𝑛𝑓, 𝜓𝐸,𝑎𝑔𝑒 , 𝜀𝑔 }. 
Flat bounded priors were used for all the parameters. We initiated 3 chains and 
set the algorithm to start adapting the size of the proposal distribution after 
1000 iterations and the shape after 500 accepted iterations.  
 
Burn-in was assessed visually after which the results of the three concurrent 
chains were combined to infer the posterior distribution. To obtain fairly 
accurate values for the 95% credible intervals, we ran the MCMC algorithm until 
the effective sample size (ESS) was ≥ 4000 (Raftery and Lewis, 1992). The three 
chains were run for 250,000 iterations each and burn-in for each chain was 
80,000, 90,000 and 80,000.  After burn-in the reminders of the three chains were 
combined into a single chain with and overall acceptance rate of 16.8%. The 
parameters were estimated on the log scale. All the computation was done using 
R software package (RStudio version 1.1.383 running R version 3.4.0 (R Core 
Team, 2017)). The code is freely available under the GNU Lesser General Public 
License v3.0 and can be found at 
https://github.com/Ikadzo/HH_Transmission_Model. 
 
Ethics statement  
For the data collection, informed written consent was obtained from all the study 
participants or their parents/guardian. The KEMRI-Scientific and Ethical Review 
Committee in Kenya provided ethical approval. The analysis presented here falls 
under the expected results from the original data collection study, however, 
additional ethical approval was obtained from the Observational / Interventions 
Research Ethics Committee at the London School of Hygiene and Tropical 
Medicine.  
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Results 
Table 2 gives a summary of the shedding episodes in the data. This particular 
outbreak had more RSV B cases than RSV A, with a significant portion of cases 
being symptomatic both for RSV A and B. Eight five percent of the households 
that were successfully followed up had an introduction of an RSV case. In 
addition to the information in Table 2; 28 (13.5%) of the total 208 episodes were 
censored during imputation; of the A and B episodes, 14 (6.7%) were 
simultaneous RSV A and B shedding episodes, 7 (3.3%) of which had a 
simultaneous onset; of the 179 individuals who got infected 31 (17.3%) were <1 
year old, 41 (22.9%) were 1-5 years, 66 (36.9%) were 5-15 years and 41 
(22.9%) ≥15 years old. Of the symptomatic infected individuals, 28 (25.7%) were 
<1 year old, 35 (32.1%) were 1-5 years, 36 (33%) were 5-15 years and 10 
(9.2%) ≥15 years old. A detailed analysis of these shedding patterns has been 
published elsewhere (Wathuo et al., 2016). Figure 2 shows the shedding pattern 
for all 179 people who had a shedding episode. Figure A.3 and Figure A.4 in the 
supplementary appendix shows the shedding and ARI patterns for RSV A and B 
respectively. 
 
Table 2: Summary of shedding episodes 
 
RSV A RSV B All RSV 
Number of episodes 97 125 208 
Number of symptomatic episodes 59 69 119 
Number of people infected 88 113 179 
Number of people with symptomatic 
episodes 
54 67 109 
Number of people with repeat 
infections 
8 12 27 
Number of households infected 
(percentage of total) 
25 
(53.2%) 
34 
(72.3%) 
40 
(85.1%) 
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Total percentage of household 
occupants that were infected  (total 
number of occupants) *  
30.0% 
(293) 
28.5% 
(396) 
40.5% 
(442) 
* The total number of infected individuals out of the total number of individuals 
that occupy the infected households.   
 
 
 
Figure 2: Shedding patterns for each of the 179 individuals who 
experienced at least one RSV shedding episode. The y-axis shows the 
household, time is on the x-axis with zero indicating the day before the first 
sample was collected. The grey dots show RSV A shedding, dark pink show RSV B 
and blue shows days of co-shedding. The horizontal grey lines separate the data 
by household. The study initially recruited 60 households but 13 were lost to 
follow-up, hence the numbering of the households goes beyond 47.  
 
Transmission model parameter inference 
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The trace plots used to assess convergence of the three chains are shown in 
Figure A.5 in the supplementary appendix. The resulting parameters estimates 
are given in Table 3 and Figure A.6. 
Table 3: Results of fitting the transmission model.  Median and 95% credible 
intervals (CrI) are given for the 15 parameters of interest. The posterior 
distribution for each parameter was obtained by running 3 MCMC chains for 
250,000 iterations each. The burn-in for the three chains was 80,000, 90,000 and 
80,000 respectively. The reminders of the three chains were combined into a 
single chain with and overall acceptance rate of 16.8% 
Parameter 
name 
Median 95% credible interval (CrI) 
Prev.hom 0.530 0.316 - 0.833 
Prev.het 0.607 0.306 - 1.08 
Sus.age.2 0.924 0.483 - 1.87 
Sus.age.3 0.267 0.142 - 0.537 
Sus.age.4 0.155 0.0825 - 0.316 
HH.rsv.a 0.0188 0.00734 - 0.0401 
HH.rsv.b 0.015 0.00578 - 0.033 
HH.size 0.424 0.265 - 0.702 
High.Asym 0.0704 0.0000692 - 3.15 
Low.Sym 2.48 1.22 - 5.57 
High.Sym 6.7 2.56 – 16.0 
Comm.rsv.a 0.00338 0.00203 - 0.00530 
Comm.rsv.b 0.00615 0.00388 - 0.00926 
Exp.age.2 0.563 0.206 - 1.45 
Exp.age.3 1.87 0.788 - 4.26 
 
In short, susceptibility to infection was reduced by previous infection whether 
these infections were homologous (Prev.hom = 0.53 (0.32 - 0.83)) or 
heterologous (Prev.het = 0.61 (0.3 - 1.1)). Increasing age also reduces 
susceptibility with ages 1-5 years old having an estimated 8% reduction  
(Sus.age.2 = 0.92 (0.48 - 1.9)), ages 5-15 years a 73% reduction (Sus.age.3 = 0.27 
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(0.14 - 0.53)) and ages >15 years an 84% reduction (Sus.age.4 = 0.16 (0.08 - 
0.32)). The within household transmission coefficients (HH.rsv.a = 0.019 (0.0073 
– 0.04) and HH.rsv.b =0.015 (0.0058 – 0.033)) are estimated higher than the 
community transmission coefficients (Comm.rsv.a = 0.0034 (0.002 – 0.0053) and 
Comm.rsv.b = 0.0062 (0.0039 – 0.0093)). The coefficient modifying within 
household exposure by size (HH.size = 0.42 (0.27 – 0.7)) suggests that larger 
households have less risk of pair-wise within household transmission 
(𝐻𝐻. 𝑅𝑖𝑠𝑘ℎ,𝑔,𝑗→𝑖(𝑡)) than smaller households. However the total risk of 
household transmission (∑ 𝐻𝐻. 𝑅𝑖𝑠𝑘ℎ,𝑔,𝑗→𝑖(𝑡)𝑗≠𝑖 ) is in general higher for larger 
households as they can have more infectious individuals at a time point, this is 
illustrated in Figure A.7.  
 
Although there is suggestion that pre-school individuals are the least likely to 
acquire infection from the community, and school-age individuals and older are 
the most likely to acquire community infection , the evidence is very weak: the 
relative estimate for age groups 1-5 years is Exp.age.2 = 0.56 (0.21 – 1.5) while 
for age group >5 years is Exp.age.3 = 1.9 (0.78 – 4.2). Symptomatic individuals 
are more infectious than asymptomatic individuals, more so those with high viral 
load, the relative estimate for high viral load symptomatic shedders is given as 
High.Sym=6.7 (2.6 – 16). However there are not enough instances where 
individuals have high viral load and are asymptomatic to quantify the relative 
infectiousness of this specific combination, the relative estimate for high viral 
load asymptomatic shedders, High.Asym, has a very wide 95% CrI. Given 71132 
person days of observation (493 individuals * 180 days of data, minus days 
individuals were away), 1021 had RSV A shedding, of which 49 were 
asymptomatic high viral load shedding days, and 1227 had RSV B shedding with 
49 days of asymptomatic high viral load shedding. Given the inability to 
distinguish between the infectiousness of high versus low viral load 
asymptomatic shedders, we will not make this distinction in subsequent results 
and instead just refer to asymptomatic shedders in general. 
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For a better understanding of the within household and community transmission 
coefficient parameters, we calculated the different rates of exposure and plotted 
them as shown in  Figure 3. 
 
 
Figure 3: Comparing the range of within household exposure rate 
(𝑯𝑯_𝑹𝒊𝒔𝒌𝒉,𝒈,𝒋→𝒊(𝒕)), (I) and (II), and community exposure rate 
(𝑪𝒐𝒎𝒎_𝑹𝒊𝒔𝒌𝒊,𝒈(𝒕)) , (III) and (IV), for a single susceptible individual given 
different heterogeneities in exposure and infectiousness.  Top row: The box 
plots show the range of values for the rate of exposure per person per day 
between a single susceptible and a single infectious housemate for RSV A (I) and 
RSV B (II). The distributions of rate are categorized by household size and the 
infectiousness based on viral load and symptom status (see text). Note: outliers 
have been removed from the box plots for better visualization. Bottom row: The 
shaded graphs show the range of values over time for the rate of exposure from 
the community to a single susceptible individual for RSV A (III) and RSV B (IV). 
The graphs are color-coded by the age group of the susceptible individual. The 
ranges for each age group are determined by the 95% CrI of the parameters that 
go into the calculations, hence the shaded regions show 95% CrI of the 
community exposure rate. 
In general, it seems the individuals are more likely to get infected within the 
household than from the community. There is a suggestion that RSV A has a 
higher transmission potential at the household level relative to RSV B, while the 
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situation is reversed at the community level. However, there is considerable 
overlap between the distributions of within household transmission coefficient 
for RSV A and that for RSV B as seen in Figure A.6, which shows the distribution 
of the parameters on the log scale, which is mirrored in the rate of household 
exposure shown in Figure 3. 
 
We observed some correlations in the estimated parameters. In particular there 
were strong positive correlations within the relative susceptibility by age 
parameters. The within household transmission coefficient for RSV A was 
strongly positively correlated with the within household transmission coefficient 
for RSV B. The age effects of susceptibility were strongly negatively correlated 
with the age effects on community exposure. Figure A. 8 in the supplementary 
index shows all the pairwise correlation patterns.  
 
To check if any information is lost when we have less data, we refitted the data in 
three additional ways: RSV A alone, RSV B alone and RSV with no distinction 
between groups. The results are shown in Table A. 1 in the supplementary index. 
In reducing the data used to infer parameters we notice that more posterior 
densities for the relative effect parameters now include 1 in their 95% credible 
interval, as can be expected. In general, the trends with age, household size and 
relative infectiousness, as seen in Figure A.6, are maintained. However, when 
RSV is treated as one entity, the protective effect of previous infection is reduced, 
symptomatic cases are more infectious and the estimate of the community 
transmission coefficient is increased. This suggests that misclassification of 
viruses disrupts the ability of the model to track transmission patterns, resulting 
in a greater propensity to account for infections as spontaneous.  
 
Model validation and sensitivity analysis 
To validate the model we checked to see that the range of simulated epidemics 
contained the real data; then we chose a single simulation with known 
parameters and re-estimated to see if the posterior distribution contained the 
known values. Details of this process can be found in the supplementary 
appendix, but in general, we were satisfied that the model was working as 
 24 
expected. Figure 4 shows multiple simulated epidemics for different parameter 
sets relative to the real data. From this we see that as with the real data, the 
simulations show the RSV B epidemic taking off earlier than the RSV A epidemic. 
There is a tendency for simulate epidemics to be larger than that observed in 
terms of total number of cases (Figure A.23). 
 
 
Figure 4: A comparison between the simulated data and real epidemics 
using simulations from 5 different parameter sets estimated from the full 
model (row 1 to 5). First column: RSV A simulated epidemics (grey lines) 
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compared to real data (thick black line). Second column: RSV B simulated 
epidemics (light blue lines) compared to real data (thick blue line). Third 
column: RSV simulated epidemics (orange lines) compared to real data (thick 
green lines). 
 
We performed a sensitivity analysis to check the robustness of our results to the 
background community density function. We used 3 additional background 
functions and found that despite a change in summary values for the parameters, 
in general the trends were maintained. These results are shown in the 
supplementary appendix. They show that the results are robust to the choice in 
the shape of background community density function. 
 
Finally, we removed the largest household (which had a very large RSV A 
outbreak but only a single RSV B case) from the data to check if this would 
change the patterns of the within household transmission coefficients. The 
results, shown in the supplementary appendix, were robust to these changes. 
 
Following the validation of the model, we simulated epidemics altering the 
degree of infectiousness. Initially we reduced the infectiousness of symptomatic 
individuals to predict the effect of reducing RSV related ARI; then we assumed 
that asymptomatic individuals are not infectious in order to quantify the 
contribution of asymptomatic infections to transmission. The results show that 
reducing infectiousness of symptomatic individuals to the level of asymptomatic 
individuals lowers the distribution of total number infected. Assuming that 
asymptomatic individuals are not infectious also tends to decrease the total 
number infected (see Figure A. 23 in the supplementary appendix).  We also 
removed the asymptomatic shedding episodes from the data and re-estimated 
the parameters to check what the effect of only having sampled symptomatic 
individuals would be. We found that we lose precision in the estimates of the 
relative infectiousness parameters, previous infection is estimated as being more 
protective as is being >15 years old (Figure A. 24 and A.25). 
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Given the posterior densities for the parameters, we calculated the source with 
the highest likelihood for each infection. While respecting the correlation 
patterns observed in Figure A.8, we sampled 10 different parameter sets and for 
each, we calculated the proportion of cases whose most likely source was an 
infectious housemate. The changes made to the likelihood equation to allow for 
this calculation are described in the supplementary appendix. For all the cases, 
32-53% of them were attributed to transmission within the household. For RSV 
A, this range was 40-59%, while for RSV B it was 26-48%.  
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Discussion 
We developed an individual based approach to make Bayesian based inference 
on transmission parameters using MCMC. We set out to better understand RSV 
transmission within a household setting using cohort data collected with 
unprecedented detail during the course of a single RSV epidemic in a rural 
coastal community in Kenya.  
 
Older individuals are less susceptible to detectable infection, presumably due to 
immunity acquired in previous epidemics. We found strong evidence of partial 
immunity to homologous re-infection within the same epidemic for the RSV 
groups. The effect of previous infections is captured in two different ways in our 
model. Age (Sus.age parameters) captures the combined effect of age and 
experience of epidemics prior to the one under study, while the estimates for the 
effect of previous observed infections (Prev.hom parameter), captures effect of 
infections in the current epidemic. It is therefore implicit that immunity to RSV is 
built up in the long term, from one epidemic to the next and in the short term 
from one infection to the next. The evidence for cross-immunity between RSV A 
and B was weaker, which presumably allowed the two virus groups to co-
circulate in this epidemic. However, typically, RSV epidemics are dominated by 
one or other of group A or B and so the particular circumstances of this epidemic 
might not always hold. It remains to be explored how this individual level 
parameter estimate is translated into population dynamics.  
 
We found some evidence that individuals aged ≥5 years were the most likely to 
get infection from a community source (less likely to get infected during a 
household outbreak). This means that given our assumption of latent periods 
between 2-5 days, which forms the temporal link between cases, individuals ≥5 
were the most often identified as index cases in a household outbreak relative to 
the younger age groups. We have not considered an age-dependent latent period, 
and estimating the latent period from these data is a future goal. The ≥5 age 
group contains school going children and our result is in line with those of 
Munywoki et al (Munywoki et al., 2014), based on a different analysis of the 
same study, who found that school-going children were often initiating 
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household outbreaks. Establishing transmission chains using genomic 
information could strengthen this result. 
 
The estimated parameters suggest that individuals were more likely to get 
infected within the household than from a source outside the household; half of 
all cases were most likely infected within the households they occupy. However, 
some caution is required as we have assumed that the community risk of 
infection changes smoothly over time and is homogeneous apart from an age 
effect. These assumptions are necessary as community infections are not 
completely observed. We are confident that these assumptions do not have 
significant influence on our estimates of within-household transmission (which 
is fully observed). Our results of about one half of infections arising from within 
the household are likely to be a minimum as community exposure will be more 
heterogeneous than we have assumed. The simulated epidemics are larger in 
total numbers than that observed, Figure 4, and we believe that this is also due to 
assumed homogeneity of community risk. Data on genetic relatedness between 
viral isolates will clarify the extent to which individuals are infected from the 
community during a household outbreak.  
 
By separating RSV A and RSV B we find that RSV B has a higher rate of 
introduction into the household, and RSV A is more transmissible once in the 
household, an observation also made by (Agoti et al., 2017) from a phylogenetic 
analysis of RSV sequences. This, together with the fact that RSV A had a larger 
proportion of cases attributed to within household transmission, suggests that 
there might be some niche separation, explaining how and why these two 
different groups are able to co-exist and remain separate. It should be noted 
however that the difference in the distribution of the within household 
transmission coefficient between the RSV groups is not large, there is a 
significant overlap of credible intervals. As such, whatever advantage RSV A 
might have over RSV B at the household level is small in terms of transmission, 
but might be larger in terms of interaction with other respiratory viruses, and 
small differences in individual based parameters might translate into large 
population effects. In the present epidemic, the RSV B epidemic takes off earlier 
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than the RSV A epidemic despite the first case being RSV A (Figure 2). In addition 
to which, we see that despite RSV B infecting more households than RSV A, RSV A 
infects a larger proportion of household members (Table 2). An examination of 
the comparative dynamics of RSV A and B within epidemics might be a good way 
to understand how they interact. 
 
With the definition of a household as a group of individuals living in the same 
compound and eating food from the same kitchen, we found that the pairwise 
rate of within household transmission is higher in small households than large 
ones. However, the total household incidence rate is in general higher for larger 
households as they have the potential to have larger numbers of infectious 
individuals at a given time point. The relationship between household size and 
pair-wise rate of transmission has been observed before for Influenza, 
(Cauchemez et al., 2009, 2004; House et al., 2012; Lau et al., 2015), however 
going a step further we show that if households are structured such that they can 
hold over 20 individuals (possibly several members of an extended family as is 
the case in the present study) then larger households will tend to contribute 
more to transmission than smaller households.  
 
We looked at a combination of presence of symptoms and viral load to infer 
infectiousness. We found that being symptomatic is of key importance. In 
general, symptomatic individuals were more infectious, particularly if shedding 
large amounts of virus. Though this result is not surprising it has an important 
implication on vaccine effectiveness. If an RSV vaccine works by reducing or 
preventing disease in the form of an ARI, this will in turn have an impact on 
transmission potential and we should expect to see reduced morbidity and 
infection. To check what that potential impact of such a vaccine would be, we 
simulated an epidemics where the infectiousness of symptomatic individuals 
was equal to that of asymptomatic individuals and we found a significant shift in 
the overall distribution of simulated case towards smaller total numbers 
infected. The shift was more for ages between 1 and 15 years, given that this 
group also had the larger fraction of symptomatic cases, the observation from 
simulations with reduced infectiousness suggests largely assortative mixing 
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within this group, which in turn means largely assortative transmission. The 
number of cases in the <1 year age group is not greatly altered by reducing the 
infectiousness of symptomatic individuals, implying that there are several 
sources of infection to the infant and reducing or removing only one has little 
impact (Figure A. 23).  
 
We reduced the model complexity to look at RSV as a single pathogen without 
distinguishing between groups. This resulted in skewing the parameter 
estimates away from within household transmission and towards spontaneous 
infection from external sources, as a result of introductions due to RSV A and 
RSV B being treated as multiple introduction of the same pathogen thus 
compounding the effect of community transmission. This, in addition to the 
reduced protective effect of previous infection due to misclassification of re-
infections, led to the within household transmission parameter being 
underestimated in order for the model to account for the observed number of 
infections. In addition, temporally linking RSV A and B cases as a result of 
misclassification also led to the effect of symptoms on transmission being 
overestimated. This suggests that the estimates obtained in the present analysis 
are likely to change if we further classified the cases into RSV subgroups. This 
goes to illustrate the importance of making distinctions between pathogens in 
order to obtain accurate estimates of transmission parameters. At any given 
moment multiple pathogens are co-circulating in a host population, this 
household study alone had multiple viruses spreading in large numbers during 
the time of data collection (Munywoki et al., 2018). How these pathogens 
interact could have dramatic implications for parameter estimates, and 
ultimately on how control strategies are implemented. We have seen the effect of 
the pneumococcal vaccine on the non-vaccine serotypes and how it might 
mitigate vaccine effectiveness (Kwambana-Adams et al., 2017) and a study on 
influenza has shown evidence of its controlling effect on other pathogens (Zheng 
et al., 2017). There is an increasing call from such observations to understand 
how multiple pathogens interact at the host population level.  
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Our study is not without limitations. The households in the study were selected 
based on the presence of an infant born after the previous RSV epidemic and 
older siblings to the infant in order to determine who infects the infant. As such 
the sample is not random and this might introduce bias in the parameter 
estimates, the extent of which we are uncertain. Relative to other studies, our 
sample size in terms of number of households is small. However, the intensive 
sampling regardless of symptoms means we had less biased observation of 
infections relative to index-case ascertained household studies that rely on 
symptom reporting by household contacts. In our study we had 47.2% of RSV A 
and 40.2% of RSV B positive samples that were symptomatic, 60.8% of RSV A 
and 55.2% of RSV B episodes were symptomatic. Estimation of parameters only 
using data from symptomatic episodes shows similar parameter estimates, 
although with loss of precision, especially in terms of differential infectiousness 
(Figure A. 24). In addition, sampling was done every 3 or 4 days, which means 
that short duration infections might have been missed, and we do not have 
serological data to complement the PCR results.  
  
The present analysis could be extended in several ways. We used interpolated 
shedding durations; it would be an added advantage to use the data to estimate a 
distribution of shedding durations that could potentially be more generalizable. 
The inclusion of other sources of information into the analysis could improve 
parameter inference, as was the case with Li et al and the inclusion of genetic 
data (Li et al., 2017). The inference made on within-household transmission 
compared to community transmission is based on the latency distribution that 
links onset of cases. This is a temporal linking of cases that is not always correct. 
A combination of temporal and genetic distance would allow better inference on 
linked cases and consequently the competition between within-household and 
community source transmission. Finally the RSV A and B model could be used to 
look at other pathogen interactions and perhaps incorporate more than two 
pathogens. 
 
In conclusion, our analysis presents the first transmission modelling of cohort 
data for RSV and we find that it is important to factor in household size and 
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social structuring – such as the tendency for households to contain several 
members of the extended family – when modelling transmission. It is also 
important to model competing risks of infection from within the household and 
the community. There are questions on the mechanisms that allow co-existence 
of RSV groups temporally and geographically. The weak cross immunity between 
RSV groups demonstrated by our analysis and the possibility of different 
transmission niches could form part of the explanation for the co-existence.   
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